455 related articles for article (PubMed ID: 23385241)
21. Specificities of the fecal microbiota in inflammatory bowel disease.
Sokol H; Seksik P; Rigottier-Gois L; Lay C; Lepage P; Podglajen I; Marteau P; Doré J
Inflamm Bowel Dis; 2006 Feb; 12(2):106-11. PubMed ID: 16432374
[TBL] [Abstract][Full Text] [Related]
22. Microbial dysbiosis in inflammatory bowel diseases: results of a metagenomic study in Saudi Arabia.
Masoodi I; Alshanqeeti AS; Ahmad S; Alyamani EJ; Al-Lehibi AA; Qutub AN; Alsayari KN; Alomair AO
Minerva Gastroenterol Dietol; 2019 Sep; 65(3):177-186. PubMed ID: 31293117
[TBL] [Abstract][Full Text] [Related]
23. Decreased colonization of fecal Clostridium coccoides/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment.
Vermeiren J; Van den Abbeele P; Laukens D; Vigsnaes LK; De Vos M; Boon N; Van de Wiele T
FEMS Microbiol Ecol; 2012 Mar; 79(3):685-96. PubMed ID: 22092917
[TBL] [Abstract][Full Text] [Related]
24. Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.
Kolho KL; Korpela K; Jaakkola T; Pichai MV; Zoetendal EG; Salonen A; de Vos WM
Am J Gastroenterol; 2015 Jun; 110(6):921-30. PubMed ID: 25986361
[TBL] [Abstract][Full Text] [Related]
25. Low counts of Faecalibacterium prausnitzii in colitis microbiota.
Sokol H; Seksik P; Furet JP; Firmesse O; Nion-Larmurier I; Beaugerie L; Cosnes J; Corthier G; Marteau P; Doré J
Inflamm Bowel Dis; 2009 Aug; 15(8):1183-9. PubMed ID: 19235886
[TBL] [Abstract][Full Text] [Related]
26. Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial.
Sadeghi O; Milajerdi A; Siadat SD; Keshavarz SA; Sima AR; Vahedi H; Adibi P; Esmaillzadeh A
Trials; 2020 Jun; 21(1):565. PubMed ID: 32576228
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
[TBL] [Abstract][Full Text] [Related]
28. Alterations in the gut microbiome of children with severe ulcerative colitis.
Michail S; Durbin M; Turner D; Griffiths AM; Mack DR; Hyams J; Leleiko N; Kenche H; Stolfi A; Wine E
Inflamm Bowel Dis; 2012 Oct; 18(10):1799-808. PubMed ID: 22170749
[TBL] [Abstract][Full Text] [Related]
29. A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients.
Takeshita K; Mizuno S; Mikami Y; Sujino T; Saigusa K; Matsuoka K; Naganuma M; Sato T; Takada T; Tsuji H; Kushiro A; Nomoto K; Kanai T
Inflamm Bowel Dis; 2016 Dec; 22(12):2802-2810. PubMed ID: 27824645
[TBL] [Abstract][Full Text] [Related]
30. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis.
Zella GC; Hait EJ; Glavan T; Gevers D; Ward DV; Kitts CL; Korzenik JR
Inflamm Bowel Dis; 2011 May; 17(5):1092-100. PubMed ID: 20845425
[TBL] [Abstract][Full Text] [Related]
31. Fecal microbial transplant via nasogastric tube for active pediatric ulcerative colitis.
Suskind DL; Singh N; Nielson H; Wahbeh G
J Pediatr Gastroenterol Nutr; 2015 Jan; 60(1):27-9. PubMed ID: 25162366
[TBL] [Abstract][Full Text] [Related]
32. The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics.
Ishikawa D; Sasaki T; Takahashi M; Kuwahara-Arai K; Haga K; Ito S; Okahara K; Nakajima A; Shibuya T; Osada T; Hiramatsu K; Watanabe S; Nagahara A
Inflamm Bowel Dis; 2018 Nov; 24(12):2590-2598. PubMed ID: 30124831
[TBL] [Abstract][Full Text] [Related]
33. Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC.
Machiels K; Sabino J; Vandermosten L; Joossens M; Arijs I; de Bruyn M; Eeckhaut V; Van Assche G; Ferrante M; Verhaegen J; Van Steen K; Van Immerseel F; Huys G; Verbeke K; Wolthuis A; de Buck Van Overstraeten A; D'Hoore A; Rutgeerts P; Vermeire S
Gut; 2017 Jan; 66(1):79-88. PubMed ID: 26423113
[TBL] [Abstract][Full Text] [Related]
34. Construction of a Model Culture System of Human Colonic Microbiota to Detect Decreased Lachnospiraceae Abundance and Butyrogenesis in the Feces of Ulcerative Colitis Patients.
Sasaki K; Inoue J; Sasaki D; Hoshi N; Shirai T; Fukuda I; Azuma T; Kondo A; Osawa R
Biotechnol J; 2019 May; 14(5):e1800555. PubMed ID: 30791234
[TBL] [Abstract][Full Text] [Related]
35. Mucosal 5-aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis.
Olaisen M; Spigset O; Flatberg A; Granlund AVB; Brede WR; Albrektsen G; Røyset ES; Gilde B; Sandvik AK; Martinsen TC; Fossmark R
Aliment Pharmacol Ther; 2019 May; 49(10):1301-1313. PubMed ID: 30895635
[TBL] [Abstract][Full Text] [Related]
36. Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease.
Aomatsu T; Imaeda H; Fujimoto T; Takahashi K; Yoden A; Tamai H; Fujiyama Y; Andoh A
Digestion; 2012; 86(2):129-35. PubMed ID: 22846404
[TBL] [Abstract][Full Text] [Related]
37. Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation.
Fuentes S; Rossen NG; van der Spek MJ; Hartman JH; Huuskonen L; Korpela K; Salojärvi J; Aalvink S; de Vos WM; D'Haens GR; Zoetendal EG; Ponsioen CY
ISME J; 2017 Aug; 11(8):1877-1889. PubMed ID: 28398347
[TBL] [Abstract][Full Text] [Related]
38. Detection of Gut Dysbiosis due to Reduced Clostridium Subcluster XIVa Using the Fecal or Serum Bile Acid Profile.
Murakami M; Iwamoto J; Honda A; Tsuji T; Tamamushi M; Ueda H; Monma T; Konishi N; Yara S; Hirayama T; Miyazaki T; Saito Y; Ikegami T; Matsuzaki Y
Inflamm Bowel Dis; 2018 Apr; 24(5):1035-1044. PubMed ID: 29688473
[TBL] [Abstract][Full Text] [Related]
39. Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis.
Öhman L; Lasson A; Strömbeck A; Isaksson S; Hesselmar M; Simrén M; Strid H; Magnusson MK
Sci Rep; 2021 Apr; 11(1):8641. PubMed ID: 33883600
[TBL] [Abstract][Full Text] [Related]
40. Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition.
Magnusson MK; Strid H; Sapnara M; Lasson A; Bajor A; Ung KA; Öhman L
J Crohns Colitis; 2016 Aug; 10(8):943-52. PubMed ID: 26896085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
